CPC A01K 67/0278 (2013.01) [A01K 67/0276 (2013.01); C07K 14/7051 (2013.01); C12N 5/0602 (2013.01); C12N 15/8509 (2013.01); G01N 33/5088 (2013.01); A01K 2207/12 (2013.01); A01K 2207/15 (2013.01); A01K 2217/072 (2013.01); A01K 2217/075 (2013.01); A01K 2217/15 (2013.01); A01K 2227/105 (2013.01); A01K 2267/01 (2013.01); A01K 2267/03 (2013.01); A01K 2267/0337 (2013.01); Y02A 50/30 (2018.01)] | 19 Claims |
1. A targeting vector comprising:
(i) a nucleic acid sequence encoding a functional chimeric human/mouse CD3ϵ protein that comprises an extracellular domain of a human CD3ϵ protein,
(ii) a nucleic acid sequence encoding a functional chimeric human/mouse CD3δ protein that comprises an extracellular domain of a human CD3δ protein,
(iii) a nucleic acid sequence encoding a functional chimeric human/mouse CD3γ protein that comprises an extracellular domain of a human CD3γ protein, and
(iv) 5′ and 3′ homology arms that are homologous to a genomic region that is 5′ to a mouse CD3ϵ gene and homologous to a genomic region that is 3′ to a mouse CD3γ gene, respectively.
|